重组生长激素治疗64例肝硬化患者糖和脂代谢变化回顾性分析
Retrospective Analysis on Glucolipid Metabolism of 64 Patients with Liver Cirrhosis after Treatment with Recombinant Growth Hormone
-
摘要: 目的 回顾性分析重组生长激素治疗对肝硬化患者糖、脂代谢的影响.方法 分析2007 年1 月至2009 年6 月64 例经重组生长激素治疗的肝硬化患者甘油三酯(TG)、血清总胆固醇(TCH)、空腹血糖(FBS)、血清胰岛素(FINS)及胰岛素抵抗指数(IRS)的影响情况.结果 肝硬化患者治疗前后各项检测指标均值无统计学差异(P＜0.05),但Child-pugh 分级的不同病程患者存在糖、脂代谢差异.结论 短期、小剂量重组生长激素辅助治疗肝硬化患者糖、脂代谢无明显影响.Abstract: Objective To retrospectively analyze the glucolipid metabolism in patients with liver cirrhosis after treatment with recombinant growth hormone.Methods We analyzed the triglycerides(TG),serum total cholesterol(TCH),fasting blood sugar(FBS),serum insulin(FINS)and insulin resistance index(IRS)in 64 patients with liver cirrhosis after treatment with recombinant growth hormone from January 2007 to June 2009.Results There was no statistically significant difference in each test index of patients with liver cirrh...
-
Key words:
- Liver cirrhosis /
- Recombinant growth hormone /
- Glucolipid metabolism
-
点击查看大图
计量
- 文章访问数: 1623
- HTML全文浏览量: 503
- PDF下载量: 30
- 被引次数: 0
下载:
